A61K 47/665
The pre-targeting system, clearing therapy or rescue therapy involving biotin- avidin systems
Official title: {the pre-targeting system, clearing therapy or rescue therapy involving biotin-(strept) avidin systems}
A61K47/665 (The pre-targeting system, clearing therapy or rescue therapy involving biotin- avidin systems) appears on 152 US grants and 169 published applications in this corpus.
Search patents in A61K- Granted patents
- 152
- Published applications
- 169
- Assignees
- 120
- Inventors
- 317
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 4 | 0 |
| 1997 | 8 | 0 |
| 1998 | 4 | 0 |
| 1999 | 10 | 0 |
| 2000 | 7 | 0 |
| 2001 | 6 | 0 |
| 2002 | 6 | 6 |
| 2003 | 6 | 20 |
| 2004 | 5 | 13 |
| 2005 | 3 | 13 |
| 2006 | 8 | 12 |
| 2007 | 4 | 14 |
| 2008 | 4 | 8 |
| 2009 | 6 | 7 |
| 2010 | 11 | 12 |
| 2011 | 10 | 10 |
| 2012 | 6 | 8 |
| 2013 | 7 | 6 |
| 2014 | 9 | 6 |
| 2015 | 3 | 3 |
| 2016 | 5 | 3 |
| 2017 | 2 | 4 |
| 2018 | 4 | 3 |
| 2019 | 1 | 4 |
| 2020 | 3 | 2 |
| 2021 | 1 | 4 |
| 2022 | 1 | 1 |
| 2023 | 1 | 1 |
| 2024 | 1 | 4 |
| 2025 | 2 | 3 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- MHC multimers, methods for their generation, labeling and use16 Jun 2026US 12,655,196 B2Agilent Technologies, Inc.
- TCO conjugates and methods for delivery of therapeutic agents25 Mar 2025US 12,257,326 B2The Regents of the University of California
- SARS-CoV-2 epitope-targeted peptide immunostimulants28 Jan 2025US 12,209,142 B2Institute for Systems Biology
- Pharmaceutical composition and kit for treating gout24 Sep 2024US 12,097,247 B2University-Industry Foundation (Uif), Yonsei University
- Affinity based drug release formulations30 May 2023US 11,660,290 B2McMaster University
- Lysosome-Mediated Degradation of Extracellular Proteins16 Jul 2026US 2026/0199495 A1Washington University
- Construction of engineered extracellular vesicle and use thereof15 Jan 2026US 2026/0015398 A1Beijing Echo Pharmaceutical Co., Ltd.
- Use of gsmtx4 and gsmtx4 conjugates to improve recovery from joint injury18 Sep 2025US 2025/0288645 A1The Research Foundation for The State University of New York
- Beads for targted signla delivery31 Jul 2025US 2025/0242045 A1Rubhu Biologics, Inc.
- Particle-bound lipid nanoparticle, method of preparation, kit, and combination composition31 Jul 2025US 2025/0242048 A1Kabushiki Kaisha Toshiba
Most cited
By later US patents
- Method for enhancing transmembrane transport of exogenous molecules352US 5,416,016 APurdue Research Foundation · 1995
- Method for enhanced transmembrane transport of exogenous molecules302US 5,108,921 APurdue Research Foundation · 1992
- Periodic constriction of vessels to treat ischemic tissue245US 6,544,543 B1Advanced Cardiovascular Systems, Inc. · 2003
- Pretargeting methods and compounds125US 6,217,869 B1NeoRx Corporation · 2001
- Composition and method for tumor imaging123US 5,688,488 APurdue Research Foundation · 1997